Rifaximin Modulates the Vaginal Microbiome and Metabolome in Women Affected by Bacterial Vaginosis

Por Laghi, Luca, Picone, Gianfranco, Cruciani, Federica, Brigidi, Patrizia, Calanni, Fiorella, Donders, Gilbert, Capozzi, Francesco, Vitali, Beatrice
Publicado em 2014

Development of a Microarray-Based Tool To Characterize Vaginal Bacterial Fluctuations and Application to a Novel Antibiotic Treatment for Bacterial Vaginosis

Por Cruciani, Federica, Biagi, Elena, Severgnini, Marco, Consolandi, Clarissa, Calanni, Fiorella, Donders, Gilbert, Brigidi, Patrizia, Vitali, Beatrice
Publicado no Antimicrob Agents Chemother (2015)

Efficacy of Rifaximin Vaginal Tablets in Treatment of Bacterial Vaginosis: a Molecular Characterization of the Vaginal Microbiota

Por Cruciani, Federica, Brigidi, Patrizia, Calanni, Fiorella, Lauro, Vittoria, Tacchi, Raffaella, Donders, Gilbert, Peters, Klaus, Guaschino, Secondo, Vitali, Beatrice
Publicado em 2012

Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach

Por Soldi, Sara, Vasileiadis, Sotirios, Uggeri, Francesca, Campanale, Mariachiara, Morelli, Lorenzo, Fogli, Maria Vittoria, Calanni, Fiorella, Grimaldi, Maria, Gasbarrini, Antonio
Publicado no Clin Exp Gastroenterol (2015)